Scroll Back to Top
Event

DIA Japan 2026 Annual Meeting Luncheon Seminar

20 October 2026
Tokyo, Japan
40 Days
11 Hours

Join Fortrea at the 23rd DIA Japan 2026 Annual Meeting in Tokyo, Japan on 20 October for our luncheon seminar on Advancing Precision Oncology for Pancreatic Cancer: Bridging Science, Clinical Practice, Patient Experience, and AI through Personalized Neoantigen Immunotherapy

Date: 1pm-2pm, 20 Oct 2026
Location: Tokyo Big Sight, 6F, Room#607

Discover how advances in precision oncology, artificial intelligence, and personalized immunotherapy are reshaping the future of pancreatic cancer treatment at Fortrea's luncheon seminar during the DIA Japan 2026 Annual Meeting.

Hosted on 20 October 2026 from 1:00-2:00 PM in Room 607 at Tokyo Big Sight, this multidisciplinary session brings together leading scientific, clinical, patient, and industry perspectives to explore the promise of personalized neoantigen immunotherapy.

The panel is delighted to bring together esteemed speakers at the cutting edge of oncology research:

  • Kazuma Kiyotani, PhD, Project Leader, Laboratory of Immunogenomics, National Institute of Biomedical Innovation, Health and Nutrition
  • Takashi Morisaki, MD, PhD, Director of Fukuoka Cancer Comprehensive Clinic, Jiseikai Medical Corporation
  • Makoto Nagaoka, PhD, Head of Regulatory Affairs Japan, Fortrea Japan K.K

Biotech and biopharma professionals will gain valuable insights into emerging precision medicine approaches, connect with key opinion leaders, and meet Fortrea's regulatory consultants to discuss strategies for advancing innovative oncology development programs

Register here for your space at the luncheon: EVENTBRITE LINK

Makoto Nagaoka, PhD is Senior Director, Regulatory Affairs and Head of Regulatory Affairs, Japan at Fortrea. With more than 20 years of experience in regulatory strategy, clinical development, and regulatory science, he advises biopharma companies on navigating Japan's regulatory landscape and advancing innovative therapies from development through approval. Dr. Nagaoka holds BS, MSc, and PhD degrees in Pharmaceutical Sciences from Kyoto University and is a licensed pharmacist in Japan